NPO Petrovax Pharm was granted official permission by the Russian Ministry of Health to produce a branded flu vaccine Grippol® Plus based on the influenza antigens synthesized at SPbSRIVS of the Russian Federal Biomedical Agency. The two companies’ joint project is being implemented within the framework of the agreement signed in 2015 on long-term
On March 18, the first group of Nicaraguan staff arrived in St. Petersburg to take part in training. Until the end of April, 25 prospective staff member of the joint Russian-Nicaraguan vaccine plant will be following a special training course and doing an internship at SPbSRIVS of the Russian Federal Biomedical Agency. In particular, as